COVID-19 Patient Proteomic Data Following Quality Control

Supplementary Material 3 from a study characterising a cohort of opportunistically recruited patients with COVID-19. The dataset contains curated proteomic data following quality control procedures, shared by author Shaufa Shareef under a CC-BY-4.0 license. It was last updated on May 12, 2026.

Use Cases

• Identifying protein biomarkers for COVID-19 severity based on curated proteomic measurements.
• Developing patient stratification models using proteomic profiles mentioned in the description.
• Validating quality control pipelines for clinical proteomic data analysis.

Strengths

• Data has undergone a described quality control process, suggesting a curated state.
• The dataset is shared under a permissive CC-BY-4.0 license for broad reuse.
• It is associated with a published clinical study on COVID-19 patient characterisation.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for large-scale modeling.
• The description metadata is limited to the title and source; detailed context requires consulting the parent study.

Provenance

Source

figshare

Collection Method

Likely generated as supplementary material for a clinical research study.

Freshness

Last updated 2026-05-12 04:43:27; freshness should be verified.